Ramsay Health Care Yönetim

Yönetim kriter kontrolleri 2/4

Ramsay Health Care CEO'su Natalie Davis, Oct2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.021% doğrudan sahiptir ve bu hisselerin değeri A$ 1.67M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.9 yıl ve 5.3 yıldır.

Anahtar bilgiler

Natalie Davis

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	0.02%
Yönetim ortalama görev süresi	2.9yrs
Yönetim Kurulu ortalama görev süresi	5.3yrs

Son yönetim güncellemeleri

Recent updates

Returns On Capital At Ramsay Health Care (ASX:RHC) Paint A Concerning Picture

Nov 11

Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden

Oct 06

Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) P/E

Sep 18

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Jul 12

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 54% Above Its Share Price

Jun 24

Shareholders Should Be Pleased With Ramsay Health Care Limited's (ASX:RHC) Price

Jun 06

Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden

May 06

CEO

Natalie Davis

less than a year

Görev süresi

Ms. Natalie Davis is Director of Ramsay Health Care Limited from December 2, 2024 and its Managing Director and Chief Executive Officer since October 2024. Ms. Davis had been Managing Director of Supermark...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Natalie Davis	MD, Group CEO & Director	less than a year	Veri yok	0.021% A$ 1.7m
Andrew Smith	Chief Financial Officer	1.3yrs	Veri yok	Veri yok
Kelly Hibbins	Group Head of Investor Relations	no data	Veri yok	Veri yok
Henrietta Rowe	Group General Counsel & Company Secretary	5.5yrs	Veri yok	Veri yok
Colleen Harris	Group Chief People Officer	no data	Veri yok	Veri yok
Andrew Wearne	Group Chief Risk Officer	no data	Veri yok	Veri yok
Rachna Gandhi	Group Chief Transformation & Digital Officer	3yrs	Veri yok	Veri yok
Carmel Monaghan	Chief Executive Officer of Ramsay Australia	4.9yrs	Veri yok	Veri yok
Pascal Roche	CEO of Ramsay Générale De Santé	no data	Veri yok	Veri yok
Nick Costa	Chief Executive Officer of Ramsay UK	2.9yrs	Veri yok	Veri yok
Joy Chamberlain	Chief Executive Officer of Elysium Healthcare	2.9yrs	Veri yok	Veri yok

2.9yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim: RHC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.9 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Natalie Davis	MD, Group CEO & Director	no data	Veri yok	0.021% A$ 1.7m
Michael Siddle	Independent Non-Executive Director	49.6yrs	AU$430.56k	1.7% A$ 134.9m
David Thodey	Independent Chairman of the Board	7.1yrs	AU$502.51k	0.0076% A$ 605.8k
Steven Sargent	Independent Non-Executive Director	3.1yrs	AU$298.76k	0.0023% A$ 183.7k
Catriona Deans	Independent Non-Executive Director	6.1yrs	AU$291.42k	0.0025% A$ 197.2k
Helen Kurincic	Independent Non-Executive Director	less than a year	AU$91.90k	0.0025% A$ 201.1k
Karen Lee Penrose	Independent Non-Executive Director	4.8yrs	AU$312.50k	0.0023% A$ 183.7k
James McMurdo	Independent Non-Executive Director	5.3yrs	AU$275.70k	0.0022% A$ 171.8k
Claudia Ricarda Suessmuth Dyckerhoff	Independent Non-Executive Director	6.2yrs	AU$292.56k	0.0027% A$ 214.6k

5.3yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RHC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/31 06:34
Gün Sonu Hisse Fiyatı	2024/12/31 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Ramsay Health Care Limited 32 Bu analistlerden 14, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
John Hester	ANZ Equities Pty Limited
Russell Wright	Barclay Pearce Capital Pty Limited
Saul Hadassin	Barrenjoey Markets Pty Limited

Ramsay Health Care Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Ramsay Health Care Limited, Annual General Meeting, Nov 26, 2024

Ramsay Health Care Announces Appointment of Helen Kurincic as Non-Executive Director, Effective March 1, 2024

Ramsay Health Care Limited, Annual General Meeting, Nov 21, 2023

Ramsay Health Care Limited, Annual General Meeting, Nov 24, 2021

Recent updates

Ramsay Health Care Limited to Report Fiscal Year 2025 Results on Aug 28, 2025

Returns On Capital At Ramsay Health Care (ASX:RHC) Paint A Concerning Picture

Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden

Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) P/E

Consensus EPS estimates fall by 22%

Price target decreased by 7.1% to AU$48.43

Final dividend increased to AU$0.40

Ramsay Health Care Limited to Report First Half, 2025 Results on Feb 27, 2025

Now 25% undervalued after recent price drop

Private Equity Reportedly Pursues Ramsay

Consensus EPS estimates increase by 22%

Consensus EPS estimates increase by 15%

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Consensus EPS estimates increase by 11%

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 54% Above Its Share Price

Shareholders Should Be Pleased With Ramsay Health Care Limited's (ASX:RHC) Price

Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden

Wesfarmers Reportedly Runs the Ruler over Ramsay Health Care

Consensus EPS estimates fall by 14%, revenue upgraded

Upcoming dividend of AU$0.40 per share

First half dividend reduced to AU$0.40

Ramsay Health Care Limited, Annual General Meeting, Nov 26, 2024

First half 2024 earnings released

New minor risk - Profit margin trend

Ramsay Health Care Announces Appointment of Helen Kurincic as Non-Executive Director, Effective March 1, 2024

Consensus EPS estimates fall by 14%

Consensus EPS estimates increase by 33%

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ramsay Health Care Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

EQT Reportedly in Hunt for Ramsay Offload

Ramsay Health Care Limited to Report First Half, 2024 Results on Feb 29, 2024

Macquarie, Columbia Asia Reportedly Among Bidders for Ramsay-Sime Darby $1.3 Billion Healthcare JV

Citi Reportedly Launches Cura Sale Process with Bids Due Next Month

Upcoming dividend of AU$0.25 per share at 1.5% yield

Consensus EPS estimates fall by 33%, revenue upgraded

New minor risk - Earnings quality

Price target decreased by 7.8% to AU$59.29

Full year 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 15%

Now 24% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of AU$0.50 per share at 1.4% yield

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ramsay Reportedly Still Weighing Options for French Stake

Ramsay Health Care Limited Announces Dividend for the Six Months Period Ending April 19, 2023, Payable on April 20, 2023

Ramsay Reportedly Looks At Hospitals Sell-Off

Ramsay Health Care Limited, Annual General Meeting, Nov 21, 2023

A consortium of financial investors including Health Employees Superannuation Trust Australia and led by KKR & Co. Inc. (NYSE:KKR) cancelled the acquisition of Ramsay Health Care Limited (ASX:RHC).

Price target decreased to AU$71.66

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 21%

Ramsay Health Care Limited Announces Ordinary Distribution for the Six Months Ended June 30, 2022 Payable on September 29, 2022

Full year 2022 earnings: EPS misses analyst expectations

Healius Reportedly Launches Day Surgery Sale Process

GIC Reportedly Eyes Ramsay Operating Company

Consensus forecasts updated

Price target increased to AU$78.38

Price target increased to AU$75.88

Investor sentiment improved over the past week

Ramsay Health Care Limited Announces Franked Dividend on RHCPA - TRANS PREF 6-BBSW+ 4.85% PERP SUB RED T-10-10 for the Six Months Period Ending October 19, 2022, Payable on October 20, 2022

Upcoming dividend of AU$0.48 per share

First half 2022 earnings: EPS exceeds analyst expectations

Ramsay Health Care Limited Announces Franked Dividend on RHCPA - TRANS PREF 6-BBSW+ 4.85% PERP SUB RED T-10-10 for the Six Months Period Ending April 19, 2022, Payable on April 20, 2022

Full year 2021 earnings released: EPS AU$1.93 (vs AU$1.31 in FY 2020)

Upcoming dividend of AU$1.03 per share

Full year 2021 earnings released: EPS AU$1.93 (vs AU$1.31 in FY 2020)

Chinese Owner’s Reportedly Hesitancy on Listing Spices Up Health Care Assets Sell-Off

Jefferies Reportedly Takes on Sale of Icon

Upcoming Dividend of AU$0.48 Per Share

Revenue and earnings beat expectations

New 90-day high: AU$68.18